Free Trial

Bio-Rad Laboratories (BIO) News Today

Bio-Rad Laboratories logo
$358.19
+27.61 (+8.35%)
(As of 10/31/2024 ET)
Bio-Rad Reports Third-Quarter 2024 Financial Results
Bio-Rad price target raised to $450 from $400 at Citi
RBC Capital Sticks to Their Buy Rating for Bio-Rad Laboratories (BIO)
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Louisiana State Employees Retirement System
Louisiana State Employees Retirement System grew its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 341.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 5,300 shares of the medical research company's stock after acquiring an additi
Bio-Rad Laboratories (BIO) Set to Announce Earnings on Wednesday
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. reduced its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 22.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,960 shares of the med
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories (BIO) Scheduled to Post Earnings on Wednesday
Bio-Rad Laboratories (NYSE:BIO) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635449)
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC decreased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 148,722 shares of the
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Up - Still a Buy?
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Up - Here's Why
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories (NYSE:BIO) Stock Price Down 2.8% - Here's What Happened
Bio-Rad Laboratories (NYSE:BIO) Shares Down 2.8% - What's Next?
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. Forecasted to Post Q3 2024 Earnings of $1.28 Per Share (NYSE:BIO)
Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Zacks Research issued their Q3 2024 earnings per share (EPS) estimates for Bio-Rad Laboratories in a research note issued to investors on Monday, October 14th. Zacks Research analyst R. Department expects that the medical research company will
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Earn Q4 2024 Earnings of $2.77 Per Share
Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Analysts at Zacks Research dropped their Q4 2024 EPS estimates for shares of Bio-Rad Laboratories in a research report issued on Monday, October 14th. Zacks Research analyst R. Department now forecasts that the medical research company will ea
Bio-Rad Laboratories, Inc. stock logo
Sanctuary Advisors LLC Buys Shares of 2,663 Bio-Rad Laboratories, Inc. (NYSE:BIO)
Sanctuary Advisors LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,663 shares of the medical research company's stock, valued at approximately $
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Sees Significant Decrease in Short Interest
Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) was the recipient of a significant drop in short interest in September. As of September 30th, there was short interest totalling 851,300 shares, a drop of 36.9% from the September 15th total of 1,350,000 shares. Based on an average daily volume of 309,900 shares, the days-to-cover ratio is presently 2.7 days. Approximately 4.5% of the company's stock are sold short.
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Truist Financial Corp
Truist Financial Corp trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 16.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,931 shares of the medical research company's stock after sel
Bio-Rad Laboratories, Inc. stock logo
RK Asset Management LLC Makes New $5.20 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)
RK Asset Management LLC bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 15,537 shares of the medical research company's stock, valued at appro
Bio-Rad Laboratories, Inc. stock logo
Paragon Capital Management Inc. Purchases Shares of 4,793 Bio-Rad Laboratories, Inc. (NYSE:BIO)
Paragon Capital Management Inc. acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,793 shares of the medical resear
Bio-Rad Laboratories, Inc. stock logo
AQR Capital Management LLC Has $13.09 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
AQR Capital Management LLC lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,954 shares of the medical research company's stock a
Expert Ratings For Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. stock logo
William B. Walkup & Associates Inc. Makes New $519,000 Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)
William B. Walkup & Associates Inc. bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,902 shares of the medical research
Bio-Rad Laboratories, Inc. stock logo
Scientech Research LLC Invests $1.19 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Scientech Research LLC acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 4,343 shares of the medical research company's stock, v
Bio-Rad Laboratories, Inc. stock logo
Select Equity Group L.P. Purchases 134,856 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Select Equity Group L.P. increased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.2% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 649,522 shares of the medical research company's sto
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Earnest Partners LLC
Earnest Partners LLC increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 17.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 606,788 shares of the medical research company's stock after a
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Brokerages
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have received a consensus rating of "Hold" from the five brokerages that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation
The gold S&P 500 stock index on a dark background with a chart of growth and fall from Japanese candlesticks, the concept of volatility in the forex market and the stock exchange, 3d rendering — Photo
S&P 500 Shake-Up: New Entrants Driving Market Momentum (BIO)
The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors.
Bio-Rad Laboratories, Inc. stock logo
Frank Rimerman Advisors LLC Acquires New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Frank Rimerman Advisors LLC purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,048 shares of the medical research company's stock
Bio-Rad Laboratories, Inc. stock logo
Sei Investments Co. Raises Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Sei Investments Co. grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 28.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 240,161 shares of the medical research company's stock af
Bio-Rad Laboratories, Inc. stock logo
XTX Topco Ltd Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)
XTX Topco Ltd acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,389 shares of the medical research company's stock, valued at approxi
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories (NYSE:BIO) Shares Down 4.3%
Bio-Rad Laboratories (NYSE:BIO) Shares Down 4.3%
Bio-Rad Laboratories, Inc. stock logo
Bio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q3 2024 Earnings of $2.13 Per Share, Zacks Research Forecasts
Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Investment analysts at Zacks Research reduced their Q3 2024 earnings per share (EPS) estimates for shares of Bio-Rad Laboratories in a note issued to investors on Tuesday, September 17th. Zacks Research analyst R. Department now expects that t
Bio-Rad Laboratories, Inc. stock logo
First Eagle Investment Management LLC Has $173.77 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
First Eagle Investment Management LLC grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 32,296.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 636,27
Bio-Rad Laboratories, Inc. stock logo
DekaBank Deutsche Girozentrale Purchases 3,252 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
DekaBank Deutsche Girozentrale increased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,587 shares of the medical research company's stock a
Bio-Rad Laboratories, Inc. stock logo
Victory Capital Management Inc. Has $5.77 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Victory Capital Management Inc. raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 18.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,108 shares of the medical re
Bio-Rad Laboratories, Inc. stock logo
Federated Hermes Inc. Purchases 4,253 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Federated Hermes Inc. lifted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 94,436 shares of the medical research comp
Bio-Rad Laboratories, Inc. stock logo
Thompson Siegel & Walmsley LLC Has $106.52 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Thompson Siegel & Walmsley LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 11.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 390,020 shares of the medical research company's s
Bio-Rad Laboratories, Inc. stock logo
Rhumbline Advisers Sells 2,457 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Rhumbline Advisers trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 6.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,863 shares of the medical research compan
Bio-Rad Laboratories, Inc. stock logo
Principal Financial Group Inc. Sells 4,383 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Principal Financial Group Inc. lessened its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 16.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,672 shares of the medical research company's stoc
Bio-Rad Laboratories, Inc. stock logo
Candriam S.C.A. Sells 36,284 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Candriam S.C.A. reduced its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 60.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 23,374 shares of the medical research company's stock a
Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

The real reason Elon is fully endorsing Trump (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

BIO Media Mentions By Week

BIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIO
News Sentiment

0.75

0.68

Average
Medical
News Sentiment

BIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIO Articles
This Week

6

6

BIO Articles
Average Week

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:BIO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners